Eric Vivier

55PUBLICATIONS
257CO-AUTHORS
Molecular targetsInnate immunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Genetic immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (55)

|Jun 05, 2026
Cytotoxic CD39<sup>+</sup> tumor-associated NK cells respond to NKG2A blockade in lung cancer.

|Apr 01, 2026
NK cells promote cardiac cell death and regulate myelopoiesis in myocardial infarction.

Raphael Cohen, Vincent Duval, Rida Al-Rifai

|Jan 30, 2026
Cross-species cellular mapping and humanization of Fcγ receptors to advance antibody modeling.

Karel F A Van Damme, Dorine Sichien, Katrien Van der Borght

|Dec 17, 2025
Bringing natural killer cells to the clinic: Opportunities beyond cancer.

Marjorie Cayatte, Valentin Picant, Marie Vétizou

|Jul 11, 2025
Innate lymphoid cells originate from fetal liver-derived tissue-resident progenitors.

Xianwei Wang, Jiarui Li, Lucas Rebuffet

|Mar 31, 2025
Genome-wide CRISPR/Cas9 screen reveals factors that influence the susceptibility of tumor cells to NK cell-mediated killing.

Sophie Guia, Aurore Fenis, Camille Baudesson De Chanville

Pageof 10

Frequent Collaborators

7 joint publications

Émilie Narni-Mancinelli

5 joint publications

Sophie Ugolini

4 joint publications

Laura Chiossone

4 joint publications

Gabrielle T Belz